Mochi Health vs bmiMD: Live Video Visits or Multi-Month Savings
Mochi Health vs bmiMD is primarily a trade-off between Mochi’s live video doctor visits and bmiMD’s multi-month pricing for compounded tirzepatide. Early verdict: choose Mochi for quick live video appointments and broad GLP-1 access; choose bmiMD if you want lower long-term monthly pricing and free subscription shipping.
Start a live video visit with Mochi
How consultations and clinician access compare
Mochi Health: Book a live video visit with a doctor in about 5 minutes. The synchronous video model is presented as a defining feature and lets a licensed physician evaluate your case during the consultation before any prescription is issued. Mochi also advertises 24/7 support and ongoing appointment availability.
bmiMD: Offers clinician-reviewed online treatment and 24/7 clinician access. The evidence highlights online refills, delivery, and clinician confirmations at regular intervals; bmiMD describes treatment as available only when a licensed clinician determines it is medically appropriate.
Check bmiMD clinician-reviewed tirzepatide plans
Mochi Health vs bmiMD: Pricing structure and commitments
Mochi uses a membership-plus-medication model with standard pricing that starts from $99/month and promotes 50% Off Your 1st Month with code BESTWLHALFOFF. Promotional offers include a $39 first-month membership rate for new customers in some states, with the standard rate noted as $79 per month after that in captured material. Mochi emphasizes that ongoing cost varies by plan and medication.
bmiMD sells compounded tirzepatide with four billing options: $179 month-to-month, $159 per month for three months, $149 per month for six months, and $139 per month for a 12-month plan. bmiMD highlights that the lowest price requires a 12-month commitment and that total prepaid charges should be confirmed. Free shipping is included on subscription orders.
View Mochi pricing and membership details
Medication options and important regulatory notes
Both providers offer compounded medications. Mochi lists compounded semaglutide and tirzepatide options with specific starting prices and also mentions compounded oral options like semaglutide pills and orforglipron. Mochi’s landing copy reiterates that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
bmiMD focuses on compounded tirzepatide and states compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. bmiMD also states medications are prepared in state-licensed pharmacies and independently verified in FDA- and DEA-registered labs in captured claims.
Shipping, refills, and delivery
Mochi: Doctor-prescribed treatments shipped to your door are promoted, with members continuing care beyond their first month. Specific shipping terms are not detailed beyond membership messaging captured.
bmiMD: Free subscription shipping on every subscription order and online refills and delivery are emphasized. bmiMD notes turnaround time and delivery to your door in captured material.
| Criteria | Mochi Health | bmiMD |
|---|---|---|
| Consultation model | Live video visits with a doctor bookable in about 5 minutes; synchronous evaluation | Clinician-reviewed online treatment with 24/7 clinician access |
| Pricing model | Membership-plus-medication; pricing starts from $99/month; 50% Off Your 1st Month with code | Tiered subscription pricing: $179/mo monthly to $139/mo for 12 months; lowest price needs commitment |
| Medication focus | Compounded semaglutide, tirzepatide, oral options; compounded medications noted | Compounded tirzepatide with same price at every dose; compounded medications noted |
| Shipping & refills | Treatments shipped to your door; members continue care beyond first month | Free subscription shipping; online refills and delivery |
| Support & access | 24/7 support plus ongoing appointments | 24/7 clinician access and online refill portal |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA | Compounded medications are not FDA-approved and are not reviewed by FDA |
What the evidence supports about outcomes and guarantees
Mochi states individual results are not guaranteed and may vary. Mochi provides an estimated result based on average self-reported member outcomes and frames it as illustrative only. bmiMD promotes a 100% risk free refund if a patient is not eligible for the program and emphasizes confirming eligibility and total prepaid charge when choosing longer commitments.
Final comparison and who should pick which provider
In summary, Mochi Health vs bmiMD presents a clear choice: Mochi centers on live synchronous video visits, membership-plus-medication pricing starting from $99/month, 24/7 support, and GLP-1 prescription access in all 50 states. bmiMD centers on tiered compounded tirzepatide subscriptions with multi-month savings, free subscription shipping, and 24/7 clinician access. Both note that compounded medications are not FDA-approved.
See bmiMD tirzepatide subscription options
Compare Mochi plans and start a video visit
Choose Mochi Health if…
- You want a live video visit with a licensed physician bookable in about 5 minutes and GLP-1 prescription access in all 50 states.
- You prefer a membership-plus-medication model with promotional 50% Off Your 1st Month options and ongoing appointment availability.
Choose bmiMD if…
- You want lower long-term monthly pricing through multi-month plans for compounded tirzepatide and free subscription shipping.
- You are prepared to confirm eligibility, total prepaid charges, and commit to a billing cadence to access the lowest monthly equivalent.